United States · Series A startup

Who invested in Seragon Pharmaceuticals

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$30Mraised across 1 round since 2013, from 1 source

Latest round
Series A, $30MOct 2013
Investors
1
See who backed them

The rounds

  1. Oct 2013
    Series A$30M

    Reported by seragonpharm.com

The exit

ExitBuyerPriceWhen
AcquiredGenentech$725MJul 2014

From historical deal records. Wrong? Tell us.

Everyone who backed them

OrbiMedPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Seragon Pharmaceuticals

Who invested in Seragon Pharmaceuticals?

Seragon Pharmaceuticals's investors include OrbiMed.

How much has Seragon Pharmaceuticals raised?

Seragon Pharmaceuticals has raised $30M across 1 round since 2013.

When did Seragon Pharmaceuticals last raise?

Seragon Pharmaceuticals's most recent round was a Series A of $30M in Oct 2013.

What was Seragon Pharmaceuticals's biggest round?

Its most recent round, $30M in Oct 2013, is also its largest on record.

Who backed Seragon Pharmaceuticals first?

Seragon Pharmaceuticals's first round on record, in Oct 2013, was backed by OrbiMed.

What stage is Seragon Pharmaceuticals at?

Seragon Pharmaceuticals's latest named round is a Series A, in Oct 2013.

Where is Seragon Pharmaceuticals based?

Seragon Pharmaceuticals is based in the United States.

Companies like Seragon Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.